Our CEO and Co-Founder, Yann Gaston-Mathé, was featured on BFM Business’s Good Morning Business TV show. He discussed the recent acquisition of Synsight and the powerful synergies it brings to our AI-driven drug discovery platform. Key topics included the integration of biological testing, generative AI, and robotics—core elements driving innovation at Iktos. Click here to watch the interview.
Back to articles
Interview: Iktos invited in Good Morning Business from BFMTV
09.19.2024